Acabrunat 100 mg Capsule

Description

Acabrunat 100 mg Capsule contains Acalabrutinib, a targeted anticancer medicine used to treat certain blood cancers. It helps slow cancer cell growth and disease progression under specialist supervision.

Benefits

• Targets malignant B-cell pathways

• Helps slow cancer growth and spread

• Can improve progression-free survival

• Oral capsule ensures convenient administration

• Effective treatment option in modern hematologic oncology

Indications and Usage

Acabrunat 100 mg Capsule is indicated for:

• Mantle Cell Lymphoma (MCL) in adults previously treated

• Chronic Lymphocytic Leukemia (CLL)

• Small Lymphocytic Lymphoma (SLL)

Treatment must be initiated and supervised by an experienced oncologist.

How it Works

Acalabrutinib selectively inhibits Bruton Tyrosine Kinase (BTK), an enzyme essential for cancerous B-cell survival and multiplication. By blocking BTK signaling, it helps slow tumor growth and disease progression.

Dosage & Administration

• Usual adult dose: 100 mg twice daily, or as prescribed

• Swallow capsule whole with water

• Take at the same times every day

• Do not crush, chew, or open the capsule

• Do not skip or double doses

• Requires routine blood tests and clinical monitoring

Use only under oncologist guidance.

Side Effects

Common side effects:

• Headache

• Fatigue

• Diarrhea

• Muscle or joint pain

• Easy bruising or bleeding

Serious side effects:

• Severe bleeding

• Serious infections

• Irregular heartbeat (atrial fibrillation)

• Secondary cancers

• Low blood cell counts

Seek immediate medical care if symptoms worsen.

Warning and Precaution

• Not recommended during pregnancy or breastfeeding

• Use cautiously in patients with bleeding disorders, heart problems, or liver disease

• Avoid live vaccines during treatment

• Increased infection risk — report fever or weakness immediately

• Inform doctor about blood thinners or ongoing medications

• Stop and seek help if allergic or hypersensitivity symptoms develop